Latest Observability News

Lightning Minerals has appointed Energold Drilling S.A. to commence a 2,000m diamond drilling program at its Esperança lithium project in Brazil, targeting spodumene-bearing pegmatites identified late last year.

Shekel Brainweigh Ltd has requested an immediate suspension from ASX quotation as it moves towards removal from the official ASX list, raising questions about the company’s future.

Spheria Emerging Companies Limited has announced a fully franked ordinary dividend of AUD 0.035 per share for the quarter ending December 2024, alongside an updated Dividend Reinvestment Plan pricing methodology.

TMK Energy has reported a staggering 300% increase in gas production in January 2025, setting a new monthly record driven by newly commissioned wells at its Gurvantes XXXV Coal Seam Gas Project.

AdAlta has fast-tracked its cellular immunotherapy growth by signing two new term sheets for clinical-stage CAR-T products from Asia, pivoting to focus on in-licensing and clinical trials while winding down internal R&D on its antifibrotic drug AD-214.

OzAurum Resources has reported a significant high-grade gold discovery at its Mulgabbie North Gold Project, highlighted by visible gold and substantial quartz veining. Follow-up drilling is set to expand on this promising find, potentially boosting the project’s value.

Connected Minerals Ltd has reported outstanding high-grade uranium results from its extended trenching and sampling program at the Etango North-East Project in Namibia, revealing multiple promising prospects and setting the stage for imminent drilling.

Fortescue Ltd has crossed the 75% ownership threshold in Red Hawk Mining, prompting an increase in its takeover offer price from A$1.05 to A$1.20 per share ahead of the March 3 closing date.

Neurizon Therapeutics has been granted a pivotal US patent for its lead drug candidate NUZ-001, extending protection until 2039 and enhancing its commercial and clinical positioning in neurodegenerative disease treatment.

Apollo Minerals has launched Phase 2 drilling at its Salanie Gold Project in Gabon, building on strong 2024 results that revealed high-grade gold mineralisation and visible gold. The program targets extensions at A1 and new prospects A2, A3, and P6.

A new peer-reviewed study highlights Cynata Therapeutics’ Cymerus™ iPSC-derived MSCs as superior to traditional donor tissue-derived MSCs in potency, consistency, and regenerative potential.

Strickland Metals has reported multiple high-grade gold intercepts from its Gradina Prospect in Serbia, confirming extensive mineralisation and paving the way for a maiden Mineral Resource Estimate later this year.